This study compared the efficacy and safety of single oral doses of 60 mg/kg and 90 mg/kg paracetamol in fit young adult patients undergoing third molar extractions. The study was a randomised, blinded, crossover design on 20 young, fit adults. Paracetamol was administered 30 minutes prior to the surgical extraction of the teeth, which was done under intravenous sedation and local anaesthesia. There were no clinically or statistically significant differences in the pain scores between 60 mg/kg or 90 mg/kg doses until the intake of rescue analgesics. There was a reduction in factor VII activity with 90 mg/kg dose compared to 60 mg/kg dose. It may be concluded that the 90 mg/kg dose, though safe, does not offer any advantages over 60 mg/kg dose of paracetamol in young fit adults undergoing third molar surgery.
Paracetamol (acetaminophen) is the most commonly used analgesic around the world. There is no clear indication in the literature about the optimal analgesic dose or maximum safe dose of paracetamol in the adult population. It appears that the analgesic dose is higher than the antipyretic dose, but the maximal effective dose has not as yet been established, though 325 to 1000 mg orally every four to six hours (max 4000 mg/day), is recommended 1, 2 . Larger than recommended doses of paracetamol are sometimes used perioperatively in adults, but have not been formally assessed for effectiveness. In addition, the safety of high therapeutic doses of paracetamol has not been evaluated fully. Paracetamol is toxic in overdose but the dose at which toxicity becomes apparent is also disputed. Single dose ingestions of up to 125 mg/kg in otherwise healthy adults do not require intervention, as they have not been reported larger doses may lead to serious hepatic and other organ damage 3 . In overdose, paracetamol has been observed to inhibit the activity of vitamin-K dependent clotting factors, in particular functional factor VII 4 . This may explain the interaction between paracetamol and warfarin.
In the present study we investigated the comparayoung, adult population undergoing surgical removal of wisdom teeth. We studied the degree of pain haematological test results as surrogate markers of safety.
METHODS
The trial was approved by the New Zealand Lower South Ethics Committee and registered with the Australian Clinical Trials Registry. Informed written consent was obtained from all the participants. The inclusion criteria were: healthy adults, ASA 1 or 2, aged 18 to 50 years scheduled for removal of bilateral, symmetrically impacted, lower or lower and upper wisdom teeth. The exclusion criteria were: intolerance to oral medications, liver or renal failure, pregnancy or breast feeding, poor nutritional status or body weight greater than 95 kg, regular use of analgesics (including paracetamol) or anticonvulsant medications, chronic ethanol abuse and history of bleeding disorders. Patients in whom surgical extraction was anticipated study.
The study had a randomised, double-blind, single-dose crossover design. Block randomisation for clusters of four was done using a random number generator on a computer. The randomisation dosage to be used for each side. The randomisation and allocation concealment were performed by the Dunedin Hospital pharmacy. Paracetamol 600 mg capsules and placebo capsules with identical appearance and weight were manufactured by the pharmacy. Upon receiving the patient's name and weight prior to the day of surgery, the pharmacy would dispense the appropriate numbers of capsules into two bottles, one with paracetamol only and the other with paracetamol and placebo, which were then dispensed in a brown bag, to be opened immediately prior to the drug administration. The side to be side was clearly labelled on one bottle; the same being true for the second side and bottle. The dose of trial drug for each side was indistinguishable and blinded to the patients, researchers and observers.
Participants were instructed to avoid analgesics including paracetamol, alcohol, herbal medicines and recreational drugs for 72 hours prior to the study and were required to fast for three hours. An intravenous cannula was inserted 30 minutes before surgery and blood samples were collected for full blood count, factor VII activity, prothrombin time (PT), international normalised ratio (INR), alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Visual analogue pain score (0 to 100 mm scale) was recorded both for continuous pain and pain on opening the mouth. The mouth-opening was measured (mm) as interincisal distance using a ruler (average of three measurements). The patient was then given the study drug (either 90 mg/kg or 60 mg/kg of paracetamol) with sips of water.
Before surgery, intravenous midazolam was administered, with the dose titrated to adequate sedative effect. The patients were monitored using pulse oximetry and non-invasive blood pressure monitors. Lignocaine (2%) with adrenaline (1:100,000) was used as the local anaesthetic agent. Inferior dental block was used to anaesthetise the inferior dental, lingual and long buccal nerves for the surgical removal of lower third molars and buccal anaesthetise the posterior superior dental and greater palatine nerves for the upper third molars. Surgery for all third molars was carried out in a standardised manner by the same surgeon. The degree of surgical and fourth postoperative days. All patients were prescribed metronidazole 400 mg three times daily They were advised to abstain from alcohol and smoking during the study period.
Visual analogue pain score for continuous pain and pain when opening the mouth was recorded at the end of the operation and at 30-minute intervals one hour from the end of operation until discharge. Rescue medication was with tablets of codeine phosphate 30 mg and diclofenac 50 mg: participants were allowed to choose any one or both of these as required, with a maximum allowable daily dose for each. Patients were instructed to record when they They were instructed to avoid additional doses of paracetamol for 48 hours. A blood sample was collected at four hours to detect the paracetamol level to rule out any toxic doses as per recommendations of the National Poison Centre 3 (which would require therapeutic intervention using N-acetyl cysteine). postoperative days and observed for any operative complications and mouth-opening was measured on those occasions. At 24 hours further blood samples were collected for full blood count, factor VII activity, PT, ALT and AST. There was an interval of at least second sides.
All the biochemical, haematological and coagulation tests (haemoglobin level, platelet count, ALT, AST, prothrombin time, factor VII activity and paracetamol blood levels) were performed in the hospital laboratories by standard commercial methods.
Non-parametric statistical tests were used for hypothesis testing of differences between VAS scores because such scores are limited at either end of the scale, and in addition, the data were not normally distributed. Comparison of median VAS was performed using the Wilcoxon signed rank test for paired data. Secondary analyses included summed pain score (2 to 8 hours post dose), using the Wilcoxon signed rank test for paired data, and a repeated measures ANOVA (2 to 8 hours post dose).
Anaesthesia and Intensive Care, Vol. 35, No. 4, August 2007 The log rank test was used for comparison of survival continuous, normally distributed outcome measures, such as changes in laboratory outcome variables. Previous studies on dental pain by members of the group 5 have indicated a maximum intensity of pain at around eight hours following third molar extractions. Using data (mean and standard deviation) from this study we estimated that 17 patients would be required for a power of 80% and a 50% decrease in pain. All statistical tests were performed using Stata ® .
RESULTS
There were 10 men and 10 women enrolled in the study. One male did not complete the second side. The median age was 22 y (range 19 to 31 y) and the median weight was 68 kg (range 50 to 95 kg). Only one patient was a regular smoker. There was no difference between the two groups in the duration of sedation, dose of midazolam, dose of local anaesthetic of operation was slightly longer in the 90 mg/kg dose (median 15 min, range 10 to 30 min) compared to 60 mg/kg dose (median 13 min, range 8 to 22 min), P=0.04.
There were no differences between the two doses in their effects upon pain scores, for either continuous pain or pain on movement, except for the eight to 10 hours post dose time point where the 60 mg/kg ( Figures 1 and 2) . The repeated measures ANOVA between the doses for continuous pain (P=0.47) or for pain on movement (P=0.84). There was no difference between doses for the sum of continuous pain scores from two to eight hours, P=0.14 (total pain for the 60 mg/kg dose, mean (95% CI): 114.21 (74.09 to 154.33), total pain for the 90 mg/kg dose: 147.83 (105.20 to 190.46)). There was no difference between doses for the sum of pain on movement from 2 to 8 hours, P=0.78 (total pain 60: 120 (71.77 to 168.22), total pain 90: 128 (85.64 to 170.36)). We constructed a survival curve for the time up to the two drug doses (log rank P restriction of mouth-opening (trismus) was present on difference between the two dosages of paracetamol ( Table 2 ). Of the 19 subjects who completed both arms of the trial, 10 subjects preferred the 60 mg/kg dose and nine preferred the 90 mg/kg dose. baseline in platelet count, ALT, AST and factor VII activity and rise in PT with both doses (Table 3 ) and a rise in INR for the 90 mg/kg dose. The fall in factor VII activity suggested a dose dependent effect.
A number of minor adverse effects were reported (Table 4 ), but there was no serious adverse event in any patient.
At four hours after initial dosing, the median (range) of plasma concentration for the 60 mg/kg dose was 233 mol/l (191 to 420) and for the 90 mg/kg dose was 417 mol/l (184 to 573). The mean (95% CI) ratio of four-hour plasma concentration for the 90 mg/kg compared with the 60 mg/kg dose was 1.61 (1.44 to 1.78). This is within the bounds for dose proportionality (ratio of 1.5). None of the blood levels at four hours were above what was considered as unsafe according to the Matthew-Rumack nomogram 6 . 
DISCUSSION
We have undertaken this study because there is limited evidence in the literature on the effectiveness and safety of high dose paracetamol used for postoperative pain control in an adult population, though use of high dose paracetamol has been reported in children without adverse effects 7 . We chose surgical extractions of impacted third molar teeth as the model since this is considered to be a for postoperative pain control and also enabled a crossover study design. There were equal numbers of of surgery and amount of local anaesthesia used.
The observed difference in the analgesic effect between the two treatments (2 mm on a 100 mm VAS) no differences between the two groups in the amount intake of rescue medication. The survival curve for any advantage for one dose over the other. All of this indicates that there is no advantage in using a 90 mg/kg dose compared to a 60 mg/kg dose.
We looked for any changes in haematological tests (haemoglobin, platelets), liver function tests (ALT and AST) and coagulation tests (PT, INR and differences in any of these tests between the two doses of paracetamol studied, although there were some within treatment changes from baseline. Previous studies have noted a transient, but noticeable inhibition of platelet function following moderate doses of paracetamol [8] [9] [10] , the later two studies showing a dose dependent inhibition. We measured factor VII activity, since it is one of the vitamin K dependent factors synthesised in the liver with a short half-life of about six hours 11, 12 . The short half-life of factor VII would ensure that any possible change in the vitamin K dependent coagulation factors manifest within 24 hours.
Factor VII activity fell at 24 hours with both doses of paracetamol, but more so with the 90 mg/kg dosage. A similar study with a smaller dose of intravenous paracetamol (propacetamol) showed no change in factor VII levels 8 of the small changes observed in our study (change of -9.5% and -18% only) is questionable. It is suggested that factor VII levels as low as 5 to 10% are adequate to prevent any abnormal bleeding in those 13 . In cases of paracetamol overdose, elevated INR as well as decreased factors VII and IX are reported 4 . The mechanism of this effect is said to be due to the production of N-acetyl-para-benzoquinone-imine (NAPQI). This chemical forms about 5% of normal metabolic product glutathione, but may escape this in overdose and affect the vitamin K cycle 14 .
There were some adverse effects noted in the postoperative period, but none of these can be attributed to paracetamol. They were more likely related to the surgery itself or the postoperative medications (codeine, diclofenac or metronidazole) and included mostly gastrointestinal symptoms such as nausea and abdominal discomfort. The surgery itself involved surgical extraction with removal of bone and this produces symptoms and signs such as swelling and trismus for a few days. There was no difference in the preference of the patients for any one treatment.
In the present study, none of the study subjects had a four-hour paracetamol level in the toxic range of the Matthew-Rumack nomogram 6 . This nomogram is a used to determine the requirement for therapy in cases of acute paracetamol overdose 15 , though its usefulness is questioned in cases of chronic overdose 16 . cause concern. The highest blood levels reached were 420 mol/l (median level of 233 mol/l) in the 60 mg/kg group and 573 mol/l (median level of 417 mol/l) in the 90 mg/kg group. This was within the bounds of dose proportionality of the two doses studied.
One possible criticism of this study is the small number of participants, leading to a type II error. Therefore we cannot exclude a small difference differences between the two doses would require a much larger sample and any differences, if present, may not be clinically relevant. The same comments apply to the lack of major adverse effects in this study, as rare adverse events would not be detected in a sample size of 20. Yet another potential confounding factor is the reliability of the nerve blocks. One cannot be assured of the completeness of the block in any subject (even though a single experienced operator provided all the blocks and all the subjects allowed the operation to satisfactorily proceed).
In conclusion, a 90 mg/kg dose of paracetamol, though safe, does not offer any advantages over 60 surgery.
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